KORU Medical Systems
Anna Majapuro-Hirvonen has extensive experience in the medical affairs sector, currently serving as Director of Medical Affairs at KORU Medical Systems since March 2018. Prior positions at KORU include Senior Manager of Medical Affairs, Senior Manager of Commercial and Clinical Development, and Clinical Affairs Manager. Before joining KORU, Anna worked at Steripolar Finland as a Product Manager and Area Manager, focusing on Vascular Access and Immunoglobulin treatment, as well as Gynecology and Obstetrics. Additional experience includes roles at Roche, Pfizer, Merck & Co., and 3M Finland. Anna holds an MBA with honors in Global Marketing and Global Management from Aalto University Executive Education and Professional Development, a Bachelor of Science in Nursing from Metropolia University, and a Midwifery degree from the Maternity Hospital in Helsinki.
This person is not in any offices
KORU Medical Systems
The home infusion industry turns to KORU Medical Systems to help patients and medical professionals improve infusion therapy experiences and we have a passion and vision for doing just that! We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers with careful consideration to the patient experience. The company was incorporated in March 1980 and is now publicly traded on the NASDAQ Capital Market (NASDAQ: KRMD). We are located in Mahwah, NJ (USA), approximately 30 miles northwest of New York City. Our primary products include the FREEDOM60® and FreedomEdge® Syringe Infusion Systems, Precision Flow Rate Tubing™, and HIgH-Flo Subcutaneous Safety Needle Sets.